Library

α-ΣΔΙΤ

α-PPP is the three-carbon homologue in the pyrrolidinophenone series (shorter alkyl chain than α-PVP and α-PBP). It acts as a potent DAT and NET inhibitor with negligible SERT activity, but uniquely also functions as a partial norepinephrine releasing agent and 5-HT2A antagonist—properties not shared by α-PVP. This 5-HT2A antagonism may contribute to its reportedly lower euphoria and reduced popularity compared to α-PVP. Community reports describe 20-40 mg insufflated or 30-60 mg oral as producing 4-6 hours of focused, relatively non-euphoric stimulation with social facilitation. Higher doses (≥90 mg oral, ≥70 mg intranasal) increase peripheral vasoconstriction, bruxism, and tremor without proportional mood elevation.

Also known as: Ppp

Classification

  • Chemical: Cathinone
  • Psychoactive: Stimulant
  • Tag: Pyrrolidine
  • Tag: Research-Chemical

Effects

  • Stimulation
  • Vasoconstriction
  • Bruxism
  • Tachycardia
  • Temperature Regulation Suppression
  • Loss Of Appetite
  • Focus Enhancement
  • Motivation Enhancement
  • Increased Sociability
  • Wakefulness
  • Anxiety
  • Compulsive Redosing
  • Appetite Suppression
  • Light Sensitivity
  • Increased Libido
  • Disinhibition
  • Dehydration
  • Tactile Enhancement

Routes of Administration

Oral

Dosage

  • Threshold: 10 mg
  • Light: 15-30 mg
  • Common: 30-60 mg
  • Strong: 60-90 mg
  • Heavy: 90+ mg

Duration

  • Onset: 0.25-0.75 h
  • Comeup: 0.33-0.67 h
  • Peak: 0.5-2 h
  • Offset: 2-3.5 h
  • After Effects: 2-12 h
  • Total Duration: 3-6 h

Insufflated

Dosage

  • Threshold: 5 mg
  • Light: 10-20 mg
  • Common: 20-40 mg
  • Strong: 40-70 mg
  • Heavy: 70+ mg

Duration

  • Onset: 0.08-0.25 h
  • Comeup: 0.17-0.33 h
  • Peak: 0.25-1.5 h
  • Offset: 1-2 h
  • After Effects: 2-12 h
  • Total Duration: 3-5 h

Vaporized

Dosage

  • Threshold: 3 mg
  • Light: 5-10 mg
  • Common: 10-25 mg
  • Strong: 25-40 mg
  • Heavy: 40+ mg

Duration

  • Onset: 0.02-0.03 h
  • Comeup: 0.05-0.08 h
  • Peak: 0.08-1 h
  • Offset: 0.8-1.5 h
  • After Effects: 2-12 h
  • Total Duration: 2-4 h

Intravenous

Dosage

  • Threshold: 20 mg
  • Light: 25-50 mg
  • Common: 50-100 mg
  • Strong: 100-150 mg
  • Heavy: 150+ mg

Duration

  • Onset: 0.004-0.016 h
  • Comeup: 0.02-0.05 h
  • Peak: 0.02-0.5 h
  • Offset: 0.5-1.5 h
  • After Effects: 2-12 h
  • Total Duration: 2-4 h

Sublingual

Dosage

  • Heavy: 80+ mg
  • Light: 15-30 mg
  • Common: 30-50 mg
  • Strong: 50-80 mg
  • Threshold: 10 mg

Duration

No data available for this section yet.

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

a-PPP - Οδηγός ουσίας DrugsPRO

a-PPP: α-PPP is the three-carbon homologue in the pyrrolidinophenone series (shorter alkyl chain than α-PVP and α-PBP). It acts as a potent DAT and NET inhibitor with negligible SERT activity, but uniquely also functions as a partial norepinephrine releasing agent and 5-HT2A antagonist—properties no

Related pages